Literature DB >> 24760789

Localization and function of dopamine receptors in the subthalamic nucleus of normal and parkinsonian monkeys.

Adriana Galvan1, Xing Hu2, Karen S Rommelfanger3, Jean-Francois Pare2, Zafar U Khan4, Yoland Smith5, Thomas Wichmann5.   

Abstract

The subthalamic nucleus (STN) receives a dopaminergic innervation from the substantia nigra pars compacta, but the role of this projection remains poorly understood, particularly in primates. To address this issue, we used immuno-electron microscopy to localize D1, D2, and D5 dopamine receptors in the STN of rhesus macaques and studied the electrophysiological effects of activating D1-like or D2-like receptors in normal and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated parkinsonian monkeys. Labeling of D1 and D2 receptors was primarily found presynaptically, on preterminal axons and putative glutamatergic and GABAergic terminals, while D5 receptors were more significantly expressed postsynaptically, on dendritic shafts of STN neurons. The electrical spiking activity of STN neurons, recorded with standard extracellular recording methods, was studied before, during, and after intra-STN administration of the dopamine D1-like receptor agonist SKF82958, the D2-like receptor agonist quinpirole, or artificial cerebrospinal fluid (control injections). In normal animals, administration of SKF82958 significantly reduced the spontaneous firing but increased the rate of intraburst firing and the proportion of pause-burst sequences of firing. Quinpirole only increased the proportion of such pause-burst sequences in STN neurons of normal monkeys. In MPTP-treated monkeys, the D1-like receptor agonist also reduced the firing rate and increased the proportion of pause-burst sequences, while the D2-like receptor agonist did not change any of the chosen descriptors of the firing pattern of STN neurons. Our data suggest that dopamine receptor activation can directly modulate the electrical activity of STN neurons by pre- and postsynaptic mechanisms in both normal and parkinsonian states, predominantly via activation of D1 receptors.
Copyright © 2014 the American Physiological Society.

Entities:  

Keywords:  dopamine; electrophysiology; parkinsonism; subthalamic nucleus; ultrastructural localization

Mesh:

Substances:

Year:  2014        PMID: 24760789      PMCID: PMC4064409          DOI: 10.1152/jn.00849.2013

Source DB:  PubMed          Journal:  J Neurophysiol        ISSN: 0022-3077            Impact factor:   2.714


  105 in total

1.  Pre- and postsynaptic localization of GABA(B) receptors in the basal ganglia in monkeys.

Authors:  A Charara; T C Heilman; A I Levey; Y Smith
Journal:  Neuroscience       Date:  2000       Impact factor: 3.590

2.  Dopamine D1/5 receptor stimulation induces c-fos expression in the subthalamic nucleus: possible involvement of local D5 receptors.

Authors:  Per Svenningsson; Catherine Le Moine
Journal:  Eur J Neurosci       Date:  2002-01       Impact factor: 3.386

3.  Cloning, molecular characterization, and chromosomal assignment of a gene encoding a second D1 dopamine receptor subtype: differential expression pattern in rat brain compared with the D1A receptor.

Authors:  M Tiberi; K R Jarvie; C Silvia; P Falardeau; J A Gingrich; N Godinot; L Bertrand; T L Yang-Feng; R T Fremeau; M G Caron
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-01       Impact factor: 11.205

4.  Comparative Ultrastructural Analysis of D1 and D5 Dopamine Receptor Distribution in the Substantia Nigra and Globus Pallidus of Monkeys.

Authors:  Michele A Kliem; Jean-Francois Pare; Zafar U Khan; Thomas Wichmann; Yoland Smith
Journal:  Adv Behav Biol       Date:  2009-08-21

5.  Evidence for physiologically active axonal adenosine receptors in the rat corpus callosum.

Authors:  T H Swanson; S E Krahl; Y Z Liu; J A Drazba; S A Rivkees
Journal:  Brain Res       Date:  1998-02-16       Impact factor: 3.252

6.  Metabotropic glutamate receptor 5 antagonist protects dopaminergic and noradrenergic neurons from degeneration in MPTP-treated monkeys.

Authors:  Gunasingh J Masilamoni; James W Bogenpohl; David Alagille; Kristen Delevich; Gilles Tamagnan; John R Votaw; Thomas Wichmann; Yoland Smith
Journal:  Brain       Date:  2011-07       Impact factor: 13.501

7.  Involvement of the subthalamic nucleus in glutamatergic compensatory mechanisms.

Authors:  E Bezard; T Boraud; B Bioulac; C E Gross
Journal:  Eur J Neurosci       Date:  1999-06       Impact factor: 3.386

8.  Localization of dopaminergic markers in the human subthalamic nucleus.

Authors:  S J Augood; Z R Hollingsworth; D G Standaert; P C Emson; J B Penney
Journal:  J Comp Neurol       Date:  2000-05-29       Impact factor: 3.215

9.  Preferential Interaction between the dopamine D2 receptor and Arrestin2 in neostriatal neurons.

Authors:  Tara A Macey; Vsevolod V Gurevich; Kim A Neve
Journal:  Mol Pharmacol       Date:  2004-09-10       Impact factor: 4.436

10.  The primate subthalamic nucleus. III. Changes in motor behavior and neuronal activity in the internal pallidum induced by subthalamic inactivation in the MPTP model of parkinsonism.

Authors:  T Wichmann; H Bergman; M R DeLong
Journal:  J Neurophysiol       Date:  1994-08       Impact factor: 2.714

View more
  16 in total

1.  Super-resolution Microscopical Localization of Dopamine Receptors 1 and 2 in Rat Hippocampal Synaptosomes.

Authors:  Andras G Miklosi; Giorgia Del Favero; Tanja Bulat; Harald Höger; Ryuichi Shigemoto; Doris Marko; Gert Lubec
Journal:  Mol Neurobiol       Date:  2017-07-22       Impact factor: 5.590

2.  Ultrapotent chemogenetics for research and potential clinical applications.

Authors:  Christopher J Magnus; Peter H Lee; Jordi Bonaventura; Roland Zemla; Juan L Gomez; Melissa H Ramirez; Xing Hu; Adriana Galvan; Jayeeta Basu; Michael Michaelides; Scott M Sternson
Journal:  Science       Date:  2019-03-14       Impact factor: 47.728

3.  Ultrastructural localization of DREADDs in monkeys.

Authors:  Adriana Galvan; Jessica Raper; Xing Hu; Jean-François Paré; Jordi Bonaventura; Christopher T Richie; Michael Michaelides; Sascha A L Mueller; Patrick H Roseboom; Jonathan A Oler; Ned H Kalin; Randy A Hall; Yoland Smith
Journal:  Eur J Neurosci       Date:  2019-06-19       Impact factor: 3.386

4.  Cortical Serotonergic and Catecholaminergic Denervation in MPTP-Treated Parkinsonian Monkeys.

Authors:  Gunasingh Jeyaraj Masilamoni; Allison Weinkle; Stella M Papa; Yoland Smith
Journal:  Cereb Cortex       Date:  2022-04-20       Impact factor: 4.861

Review 5.  Chronic MPTP administration regimen in monkeys: a model of dopaminergic and non-dopaminergic cell loss in Parkinson's disease.

Authors:  Gunasingh J Masilamoni; Yoland Smith
Journal:  J Neural Transm (Vienna)       Date:  2017-08-31       Impact factor: 3.575

6.  Quantification of movement in normal and parkinsonian macaques using video analysis.

Authors:  Michael Caiola; Damien Pittard; Thomas Wichmann; Adriana Galvan
Journal:  J Neurosci Methods       Date:  2019-05-02       Impact factor: 2.390

7.  Anatomical localization of Cav3.1 calcium channels and electrophysiological effects of T-type calcium channel blockade in the motor thalamus of MPTP-treated monkeys.

Authors:  Annaelle Devergnas; Erdong Chen; Yuxian Ma; Ikuma Hamada; Damien Pittard; Stefan Kammermeier; Ariana P Mullin; Victor Faundez; Craig W Lindsley; Carrie Jones; Yoland Smith; Thomas Wichmann
Journal:  J Neurophysiol       Date:  2015-11-04       Impact factor: 2.714

8.  Structural plasticity of GABAergic and glutamatergic networks in the motor thalamus of parkinsonian monkeys.

Authors:  Ashley J Swain; Adriana Galvan; Thomas Wichmann; Yoland Smith
Journal:  J Comp Neurol       Date:  2019-12-16       Impact factor: 3.215

9.  Lack of Antiparkinsonian Effects of Systemic Injections of the Specific T-Type Calcium Channel Blocker ML218 in MPTP-Treated Monkeys.

Authors:  Adriana Galvan; Annaelle Devergnas; Damien Pittard; Gunasingh Masilamoni; Jocelyn Vuong; J Scott Daniels; Ryan D Morrison; Craig W Lindsley; Thomas Wichmann
Journal:  ACS Chem Neurosci       Date:  2016-09-20       Impact factor: 4.418

10.  Effects of Optogenetic Activation of Corticothalamic Terminals in the Motor Thalamus of Awake Monkeys.

Authors:  Adriana Galvan; Xing Hu; Yoland Smith; Thomas Wichmann
Journal:  J Neurosci       Date:  2016-03-23       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.